risperidone has been researched along with Fra(X) Syndrome in 3 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this study was to assess the effectiveness of risperidone monoantipsychotic therapy targeting irritability in patients with Fragile X syndrome (FXS) in a naturalistic outpatient clinical setting." | 7.88 | Risperidone Treatment for Irritability in Fragile X Syndrome. ( Dominick, KC; Erickson, CA; Pedapati, EV; Shaffer, R; Sweeney, JA; Wink, LK, 2018) |
| "The goal of this study was to assess the effectiveness of risperidone monoantipsychotic therapy targeting irritability in patients with Fragile X syndrome (FXS) in a naturalistic outpatient clinical setting." | 3.88 | Risperidone Treatment for Irritability in Fragile X Syndrome. ( Dominick, KC; Erickson, CA; Pedapati, EV; Shaffer, R; Sweeney, JA; Wink, LK, 2018) |
| " They responded well to the reduction in dosage or to withdrawal of the apparent causing agent." | 2.49 | [Medication-related oculogyric crises: a description of four cases and a review of the literature]. ( Campistol, J; Darling, A; Perez-Duenas, B; Poo, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckert, EM | 1 |
| Dominick, KC | 2 |
| Pedapati, EV | 2 |
| Wink, LK | 2 |
| Shaffer, RC | 1 |
| Andrews, H | 1 |
| Choo, TH | 1 |
| Chen, C | 1 |
| Kaufmann, WE | 1 |
| Tartaglia, N | 1 |
| Berry-Kravis, EM | 1 |
| Erickson, CA | 2 |
| Shaffer, R | 1 |
| Sweeney, JA | 1 |
| Darling, A | 1 |
| Poo, P | 1 |
| Perez-Duenas, B | 1 |
| Campistol, J | 1 |
1 review available for risperidone and Fra(X) Syndrome
| Article | Year |
|---|---|
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Ch | 2013 |
2 other studies available for risperidone and Fra(X) Syndrome
| Article | Year |
|---|---|
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
Topics: Adolescent; Adult; Aggression; Antidepressive Agents; Antipsychotic Agents; Child; Comorbidity; Cros | 2019 |
Risperidone Treatment for Irritability in Fragile X Syndrome.
Topics: Adolescent; Adult; Antipsychotic Agents; Child; Child, Preschool; Drug Therapy, Combination; Fragile | 2018 |